US2023390318A1PendingUtilityA1

Antiviral Prodrugs and Pharmaceutical Compositions Thereof

Assignee: SCRIPPS RESEARCH INSTPriority: Sep 11, 2019Filed: Aug 15, 2023Published: Dec 7, 2023
Est. expirySep 11, 2039(~13.1 yrs left)· nominal 20-yr term from priority
C07H 19/20A61P 31/14A61P 31/12A61P 31/20A61K 45/06A61K 47/14A61K 47/26A61K 31/513A61K 31/675A61K 31/4439A61K 31/5365A61K 31/7076A61K 31/4985A61P 31/18C07H 19/173A61K 47/38A61K 9/10A61K 9/0019C07H 19/16
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Diesters of 4′-ethynyl-2-fluoro-2′-deoxyadenosine and aqueous parenteral suspensions thereof provide extended in vivo viral suppression of human immunodeficiency virus (HIV).

Claims

exact text as granted — not AI-modified
1 .- 36 . (canceled) 
     
     
         37 . A compound, which is: 
       
         
           
           
               
               
           
         
       
     
     
         38 . A compound, which is: 
       
         
           
           
               
               
           
         
       
     
     
         39 . A compound, which is:

Join the waitlist — get patent alerts

Track US2023390318A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.